Sysmex Corporation (SSMXF)
SSMXF Stock Price Chart
Explore Sysmex Corporation interactive price chart. Choose custom timeframes to analyze SSMXF price movements and trends.
SSMXF Company Profile
Discover essential business fundamentals and corporate details for Sysmex Corporation (SSMXF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
21 Apr 2009
Employees
10.04K
Website
https://www.sysmex.co.jpCEO
Kaoru Asano
Description
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, it offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; and lab assay services. Further, the company is involved in the development and sale of software for diagnostic information systems; provision of facility management, office, welfare, and genetic analysis services; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. Additionally, it researches, develops, manufactures, and sells regenerative medicine products; develops, manufactures, and sells biodevices; develops, maintains, and sells computer software; and offers blood DNA testing service. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
SSMXF Financial Timeline
Browse a chronological timeline of Sysmex Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 10 Feb 2026
Upcoming earnings on 5 Nov 2025
Revenue estimate is $922.90M.
Earnings released on 6 Aug 2025
EPS came in at $0.05 falling short of the estimated $0.12 by -57.44%, while revenue for the quarter reached $733.67M , missing expectations by -20.93%.
Earnings released on 14 May 2025
EPS came in at $0.12 falling short of the estimated $0.15 by -20.79%, while revenue for the quarter reached $974.86M , beating expectations by +20.05%.
Dividend declared on 14 May 2025
A dividend of $0.13 per share was announced, adjusted to $0.13.
Dividend declared on 14 May 2025
A dividend of $0.13 per share was announced, adjusted to $0.13. The dividend will be paid on 1 Dec 2025.
Earnings released on 12 Feb 2025
EPS came in at $0.17 surpassing the estimated $0.15 by +10.35%, while revenue for the quarter reached $791.10M , missing expectations by -17.25%.
Earnings released on 6 Nov 2024
EPS came in at $0.17 surpassing the estimated $0.16 by +5.70%, while revenue for the quarter reached $908.12M , beating expectations by +1.83%.
Earnings released on 6 Aug 2024
EPS came in at $0.11 surpassing the estimated $0.10 by +9.77%, while revenue for the quarter reached $696.98M , beating expectations by +1.96%.
Earnings released on 9 May 2024
EPS came in at $0.16 falling short of the estimated $0.17 by -4.42%, while revenue for the quarter reached $889.82M , beating expectations by +5.49%.
Dividend declared on 9 May 2024
A dividend of $0.11 per share was announced, adjusted to $0.10. The dividend was paid on 30 Jun 2025.
Dividend declared on 9 May 2024
A dividend of $0.10 per share was announced, adjusted to $0.10. The dividend was paid on 3 Dec 2024.
Stock split effective on 9 Apr 2024
Shares were split 3 : 1 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 28 Mar 2024
Shares were split 3 : 1 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 Feb 2024
EPS came in at $0.14 falling short of the estimated $0.17 by -16.65%, while revenue for the quarter reached $813.66M , missing expectations by -0.51%.
Earnings released on 30 Sept 2023
EPS came in at $0.14 surpassing the estimated $0.13 by +13.07%, while revenue for the quarter reached $785.25M , beating expectations by +1.61%.
Earnings released on 30 Jun 2023
EPS came in at $0.09 falling short of the estimated $0.12 by -22.50%, while revenue for the quarter reached $659.78M , missing expectations by -4.33%.
Dividend declared on 11 May 2023
A dividend of $0.28 per share was announced, adjusted to $0.09. The dividend was paid on 24 Jun 2024.
Dividend declared on 11 May 2023
A dividend of $0.28 per share was announced, adjusted to $0.09. The dividend was paid on 4 Dec 2023.
Earnings released on 31 Mar 2023
EPS came in at $0.13 falling short of the estimated $0.19 by -33.68%, while revenue for the quarter reached $843.45M , missing expectations by -8.19%.
Earnings released on 9 Feb 2023
EPS came in at $0.41 surpassing the estimated $0.39 by +3.64%, while revenue for the quarter reached $807.33M , beating expectations by +0.67%.
Earnings released on 9 Nov 2022
EPS came in at $0.54 surpassing the estimated $0.15 by +250.56%, while revenue for the quarter reached $746.87M , beating expectations by +6.65%.
Earnings released on 4 Aug 2022
EPS came in at $0.29 falling short of the estimated $0.35 by -17.21%, while revenue for the quarter reached $632.93M , missing expectations by -1.02%.
Earnings released on 12 May 2022
EPS came in at $0.41 falling short of the estimated $0.41 by -0.02%, while revenue for the quarter reached $857.70M , beating expectations by +6.66%.
Dividend declared on 12 May 2022
A dividend of $0.32 per share was announced, adjusted to $0.10. The dividend was paid on 26 Jun 2023.
Dividend declared on 12 May 2022
A dividend of $0.28 per share was announced, adjusted to $0.09. The dividend was paid on 5 Dec 2022.
Earnings released on 10 Feb 2022
EPS came in at $0.44 falling short of the estimated $0.49 by -9.51%, while revenue for the quarter reached $783.76M , beating expectations by +0.99%.
Earnings released on 10 Nov 2021
EPS came in at $0.52 surpassing the estimated $0.29 by +79.82%, while revenue for the quarter reached $802.51M .
Earnings released on 6 Aug 2021
EPS came in at $0.44 surpassing the estimated $0.33 by +31.69%, while revenue for the quarter reached $714.08M .
Earnings released on 12 May 2021
EPS came in at $0.43 falling short of the estimated $0.45 by -5.02%, while revenue for the quarter reached $843.39M .
Dividend declared on 12 May 2021
A dividend of $0.32 per share was announced, adjusted to $0.10. The dividend was paid on 27 Jun 2022.
Dividend declared on 12 May 2021
A dividend of $0.33 per share was announced, adjusted to $0.11. The dividend was paid on 6 Dec 2021.
Earnings released on 3 Feb 2021
EPS came in at $0.48 surpassing the estimated $0.44 by +8.78%, while revenue for the quarter reached $771.94M .
Earnings released on 5 Nov 2020
EPS came in at $0.38 falling short of the estimated $0.39 by -3.12%, while revenue for the quarter reached $678.01M .
Dividend declared on 12 May 2020
A dividend of $0.33 per share was announced, adjusted to $0.11. The dividend was paid on 28 Jun 2021.
Dividend declared on 12 May 2020
A dividend of $0.34 per share was announced, adjusted to $0.11. The dividend was paid on 1 Dec 2020.
SSMXF Stock Performance
Access detailed SSMXF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.